OurView Health review
OurView offers dose-independent monthly pricing, an authorization before clinical approval, and a patient portal for follow-up.
The verdict
OurView charges $109 a month for compounded semaglutide and $129 for compounded tirzepatide. Both are month-to-month rates. Paying three months at once lowers each by ten dollars. No membership fee applies.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- Dose pricing
- Flat across doses
- From
- From $109/mo
- Dose published
- No
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Pharmacy
- Not named
- Availability
- 46 states and DC
- LegitScript
- Claimed by provider
OurView is an online platform for weight loss, hormone and wellness care. The GLP-1 line is compounded semaglutide and compounded tirzepatide. The footer calls OurView a patient management platform. Independent physician networks and a licensed U.S. pharmacy deliver the care.
Who writes the prescription, and what do they see?
OurView separates its platform from the independent clinicians who deliver care. A U.S.-licensed provider reviews health history and determines suitability after intake. Checkout authorizes the payment method, but the FAQ says the charge is finalized only after treatment approval. If treatment is declined, the authorization is released. A payment hold is therefore not a promise that a prescription will follow.
The patient portal is the route for account details and messages to the care team. The published sequence is treatment selection, health assessment, provider review, then pharmacy fulfillment. Each supply is described as 30 days. OurView lists service in 46 states plus DC, excluding Arkansas, Connecticut, Hawaii and New Jersey. Confirm availability before transferring care, particularly when a move would put you in an excluded state.
What happens when the dose goes up?
The price is stated to hold at any prescribed dose. The homepage repeats this on both product cards. No milligram dose is published for either molecule. Who approves a dose change is described only as the provider.
What the price includes
The monthly prices remain $109 for semaglutide and $129 for tirzepatide. A prepaid quarter reduces each monthly equivalent by ten dollars; semaglutide costs $297 upfront. Membership and delivery carry no separate charge. Prescription sales become final after payment and handoff to the carrier. Cancel through the account before shipment. The policy does not promise a refund for unused portions of a prepaid quarter.
What it claims, and what it cites
The treatments are compounded and are not FDA-approved products. OurView describes licensed pharmacy fulfillment but does not identify the assigned dispenser on its treatment cards. Its return policy names Boudreaux’s New Drug Store as a return address; that alone does not establish who fills every GLP-1 order. Ask for the pharmacy name and follow the storage directions supplied with the actual prescription.
Where it holds up, and where it does not
- Strength: Month-to-month rates on both molecules
- Strength: Price stated as the same at any dose
- Strength: No membership fee and no shipping fee
- Strength: Prepay saving stated in dollars
- Strength: LegitScript approval displayed
- Limitation: Assigned clinician and pharmacy need confirmation
- Limitation: No complete milligram schedule beside pricing
- Limitation: Four states excluded from service
- Limitation: Unused prepaid months lack an explicit refund promise
What the evidence says about this kind of treatment
The assessment above is about OurView Health. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A patient comfortable with remote assessment who wants the prescribed dose to leave the monthly bill unchanged.
- Wrong for
- Someone needing in-person follow-up or a guaranteed refund for unused prepaid medication.
The evidence behind what OurView Health prescribes
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Cochrane Review of Semaglutide for Obesity: 18 Trials Graded
A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
- Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
How OurView Health compares
| Seller | Who it suits | Go |
|---|---|---|
 Yucca Health | Buyers who want the whole ladder visible before intake and may not stay six months | See Yucca Health → |
 EOS Health | Buyers who want the renewal rate printed beside the introductory one, on every plan | See EOS Health → |
 FMmeds | Buyers who want one all-in figure and the compounding pharmacy named beside it | See FMmeds → |
More GLP-1 telehealth sellers reviews: Genesis Lifestyle MedicineGide HealthGlowGOAL.MDGoodLife HealthHappy Care Meds
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- When does OurView charge the card?
- The FAQ describes an initial authorization followed by a finalized charge after treatment approval. A declined treatment releases the authorization.
- Does the monthly price change at higher doses?
- OurView advertises $109 for semaglutide and $129 for tirzepatide at any prescribed dose. The clinician still determines which dose is appropriate.
- Is OurView available in every state?
- No. Its FAQ excludes Arkansas, Connecticut, Hawaii and New Jersey, while listing the remaining states and DC.
- What happens if a package is lost?
- Contact the patient care team. The return policy says OurView first works with the carrier to locate the shipment and will reship a lost order.
- Is OurView Health legit?
- OurView Health is a GLP-1 telehealth sellers service. Its stated availability: 46 states and DC. It displays a LegitScript certification claim, which we record as a claim and not as a verified fact: LegitScript's public checker is gated and returns the same page for any domain put into it, so no one can reproduce a check from it. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay.
- Is OurView Health expensive compared with other GLP-1 telehealth sellers?
- OurView Health publishes a starting figure of $109/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts OurView Health below the median, toward the cheaper end. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.
Sources for this review
Provider information checked . Terms can change.